Search Results
Mar 27, 2026, 14:13 ET Visitors are Invited to Experience the Spirit of Miami Beach -- Where Pride, Passion, and Community Take Center Stage
@ExperienceMiamiBeach on Instagram and download the EXP Miami Beach Tours App, available via the App Store and Google Play.For press inquiries, please contact Private Label Marketing at
More news about: Miami Beach Visitor and Convention Authority
Mar 24, 2026, 09:03 ET Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia
dermal papilla cells promote hair growth in cultured human hair follicles and augment the hair-inductive capacity of cultured dermal papilla spheres. Exp Dermatol. 2019;28(7):854-857.⁶ Rajendran RL, Gangadaran P, Bak SS, et al. Extracellular vesicles derived from MSCs activates dermal papilla
More news about: Xtressé™
Mar 04, 2026, 10:50 ET Kelsey H. Collins, PhD, Wins NEXT Award for Translational Research on Relationship between Fat and Osteoarthritis Development and Pain
https://www.arthritis.org/diseases/osteoarthritis. Accessed Jan. 12, 2026.ii Hawker GA. 2019. Osteoarthritis is a serious disease. Clin Exp Rheumatol 37 Suppl 120:3-6.iii Griffin TM, Huebner JL, Kraus VB, Guilak F. Extreme obesity due to impaired leptin signaling in mice
More news about: American Academy of Orthopaedic Surgeons
Feb 25, 2026, 03:00 ET RAVEN2 OPENS THE FIRST-EVER BOOST SERVER "BURNING" WITH MASSIVE GROWTH REWARDS
As they level up, they will also earn a Heroic Equipment Set and BURNING Level Chests at designated milestones, which include a variety of items and EXP support to help speed up progression. Players who reach Level 60 will receive a Legendary Holy Garment, and the same reward will be granted to all players
More news about: Netmarble
Feb 25, 2026, 01:00 ET RAVEN2 DEVASA BÜYÜME ÖDÜLLERİYLE İLK DESTEK SUNUCUSU "YANMA"YI AÇIYOR
ulaştıklarında bir Şanlı Kutsal Kıyafet ve bir Şanlı Tanıdık elde edebilirler. Seviye atladıkça, ilerlemeyi hızlandırmaya yardımcı olmak için çeşitli eşyalar ve EXP desteği içeren bir Şanlı Teçhizat Seti ve belirlenen kilometre taşlarında YANAN Seviye Göğüs de kazanacaklar. Seviye 60'a ulaşan oyuncular Efsanevi Kutsal
More news about: Netmarble
Feb 23, 2026, 09:00 ET Chime Enterprise Adds New Employer Partners as Demand Grows for Comprehensive Financial Wellness
Cedarhurst Senior Living, eXp Realty, and LRS (Lakeshore Recycling Systems) adopt Chime Workplace to strengthen employee financial health and workforce productivityEmployers move beyond standalone earned wage access as financial wellness becomes core to workplace benefits
More news about: Chime Enterprise
Feb 23, 2026, 08:47 ET Experience Miami Beach Through Iconic Culinary Traditions This Season
www.experiencemiamibeach.com, follow @ExperienceMiamiBeach Instagram and download the EXP Miami Beach Tours App, available via the App Store and Google Play.For press inquiries, please contact Private Label Marketing at
More news about: Miami Beach Visitor and Convention Authority
Feb 17, 2026, 06:45 ET Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters
Other Operating (Inc.)/Exp., net as a % of Net Sales
More news about: Medtronic plc
Feb 16, 2026, 08:00 ET Glitter, maquiagem e calor: como evitar acne e irritações na pele durante o Carnaval
(CORNEOMETRIA) DO PRODUTO DE U; N= 279-10. ESTUDO CLÍNICO DO POTENCIAL ACNEGÊNICO E COMEDOGÊNICO E DA; 7.17706174 Knackstedt R et al. Exp Dermatol. 2020 Jan;29(1):15-2111. GLI.04.SPR.US10378_FIL 140912-13. Data on File: Fórmula FIL 140914-16. GLI.04.SPR.US10377_FIL
More news about: Galderma
Feb 13, 2026, 16:53 ET EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA® VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
die Synthese von Anti-Acetylcholin-Rezeptor-Antikörpern durch kultivierte Thymozyten und Blutlymphozyten bei Myasthenia gravis erforderlich sind. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantikörper produzierende Plasmablasten nach B-Zell-Depletion bei
More news about: Amgen
Feb 13, 2026, 14:41 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK UPLIZNA® OD SPOLOČNOSTI AMGEN NA LIEČBU GENERALIZOVANEJ MYASTÉNIE GRAVIS
Typy buniek potrebné na syntézu protilátok proti acetylcholínovému receptoru kultivovanými tymocytmi a krvnými lymfocytmi pri myasténii gravis. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P., Kumar A., Nowak RJ., O'Connor KC. Plazmablasty produkujúce autoprotilátky po deplécii B buniek identifikované
More news about: Amgen
Feb 13, 2026, 11:47 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN UPLIZNA ® ДЛЯ ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАННОЙ МИАСТЕНИИ
Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified
More news about: Amgen
Feb 13, 2026, 11:41 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol. (1984) 58:97-106Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion
More news about: Amgen
Feb 13, 2026, 09:34 ET KOMISJA EUROPEJSKA ZATWIERDZA LEK UPLIZNA® FIRMY AMGEN W LECZENIU UOGÓLNIONEJ MIASTENII
gravis (Typy komórek niezbędne do syntezy przeciwciał przeciwko receptorowi acetylocholiny przez wyhodowane tymocyty i limfocyty krwi w miastenii). Clin Exp Immunol. 1984; 58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified
More news about: Amgen
Feb 12, 2026, 19:00 ET Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer
[2] Tan M， Yu D. Molecular mechanisms of erbB2-mediated breast cancer chemoresistance. Adv Exp Med Biol. 2007;608:119-129. doi:10.1007/978-0-387-74039-3_9.
More news about: Innovent Biologics
Feb 12, 2026, 15:30 ET LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE
Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified
More news about: Amgen
Feb 12, 2026, 15:15 ET La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada
Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified
More news about: Amgen
Feb 12, 2026, 09:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol. 1984;58:97-106.Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified
More news about: Amgen
Feb 12, 2026, 06:30 ET Entergy reports 2025 financial results, initiates 2026 guidance
Operating revenue less: fuel, fuel-related exp. and gas purch. for resale; purch. power; and other reg. chgs. (credits) – net
More news about: Entergy Corporation
Feb 11, 2026, 09:42 ET Polymetallic Explorers Gain Ground as Copper Deficit Reshapes Discovery Premiums
million to EXP Services for project management and engineering support during the construction phase of its Ontario cobalt sulfate refinery. The facility is advancing toward mechanical completion in H1 2027 with commissioning and production expected in the following months."Partnering with EXP provides
More news about: Equity Insider
Feb 05, 2026, 11:44 ET FIS completa con éxito la emisión de bonos por valor de 770 millones de euros
& Poor's ratificó la Calificación Crediticia del Emisor (ICR) de B con perspectiva estable. Las calificaciones de los Bonos son B2 (Moody's), BB- (EXP) (Fitch) y B (Standard & Poor's)."Estamos muy satisfechos con el resultado de esta emisión de bonos", declaró Daniele Piergentili,
More news about: FIS
Feb 05, 2026, 11:37 ET FIS CONCLUT AVEC SUCCÈS L'ÉMISSION D'OBLIGATIONS POUR UN MONTANT DE 770 MILLIONS D'EUROS
and Poor's a confirmé la note de crédit de l'émetteur (ICR) de B avec perspectives stables. Les notes attribuées aux billets sont B2 (Moody's), BB- (EXP) (Fitch) et B (Standard and Poor's).« Nous sommes très satisfaits du résultat de cette émission d'obligations », a déclaré Daniele Piergentili,
More news about: FIS
Feb 05, 2026, 10:03 ET FIS SCHLIESST ANLEIHEEMISSION IN HÖHE VON 770 MILLIONEN EURO ERFOLGREICH AB
während Standard and Poor's das Issuer Credit Rating (ICR) von B mit stabilem Ausblick bestätigte. Die Ratings für die Anleihen sind B2 (Moody's), BB- (EXP) (Fitch) und B (Standard and Poor's).„Wir sind sehr zufrieden mit dem Ergebnis dieser Anleiheemission", sagte Daniele Piergentili,
More news about: FIS
Feb 05, 2026, 09:09 ET FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
outlook), while Standard and Poor's affirmed the Issuer Credit Rating (ICR) of B rating with stable outlook. Ratings for the Notes are B2 (Moody's), BB- (EXP) (Fitch) and B (Standard and Poor's)."We are very pleased with the outcome of this bond issuance," - said Daniele Piergentili, CEO
More news about: FIS
Feb 05, 2026, 09:04 ET FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
outlook), while Standard and Poor's affirmed the Issuer Credit Rating (ICR) of B rating with stable outlook. Ratings for the Notes are B2 (Moody's), BB- (EXP) (Fitch) and B (Standard and Poor's)."We are very pleased with the outcome of this bond issuance," - said Daniele Piergentili, CEO
More news about: FIS